WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

BioMarin to seek further approval of Voxzogo in form of short stature

BioMarin Pharmaceutical will seek expanded approval for its bone growth-stimulating drug Voxzogo after the shot improved growth speed in children with a form of short stature, the company said Wednesday.

Raccontata dabiopharmadive.comfiercepharma.comendpoints.news

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
endpoints.newsStai leggendo1 mesi fa

BioMarin to seek further approval of Voxzogo in form of short stature

BioMarin Pharmaceutical will seek expanded approval for its bone growth-stimulating drug Voxzogo after the shot improved growth speed in children with a form of short stature, the company said Wednesday.

originale
biopharmadive.com1 mesi fa

BioMarin notches win in study that could expand use of top-selling medicine

The success came two days after a Phase 3 setback for another experimental drug and helps improve the position of Voxzogo amid increased competition.

Leggi questa versione → originale
fiercepharma.com1 mesi fa

With Voxzogo under pressure, BioMarin touts trial win in label expansion bid

With phase 3 results that have “exceeded” BioMarin’s expectations, according to R&D chief Greg Friberg, M.D., the California biotech appears set up to gain a label expansion for its top-selling | With phase 3 results…

Leggi questa versione → originale

Timeline cronologica

  1. giovedì 21 maggio 2026·biopharmadive.com

    BioMarin notches win in study that could expand use of top-selling medicine

    The success came two days after a Phase 3 setback for another experimental drug and helps improve the position of Voxzogo amid increased competition.

  2. giovedì 21 maggio 2026·fiercepharma.com

    With Voxzogo under pressure, BioMarin touts trial win in label expansion bid

    With phase 3 results that have “exceeded” BioMarin’s expectations, according to R&D chief Greg Friberg, M.D., the California biotech appears set up to gain a label expansion for…

  3. giovedì 21 maggio 2026·endpoints.news

    BioMarin to seek further approval of Voxzogo in form of short stature

    BioMarin Pharmaceutical will seek expanded approval for its bone growth-stimulating drug Voxzogo after the shot improved growth speed in children with a form of short stature, the…